The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akwel SA
LSE:0F8V
|
FR |
|
Lam Research Corp
NASDAQ:LRCX
|
US |
|
SLB NV
NYSE:SLB
|
US |
|
E
|
Essilorluxottica SA
MIL:1EL
|
FR |
|
A
|
Acsion Ltd
JSE:ACS
|
ZA |
|
Batliboi Ltd
BSE:522004
|
IN |
|
Gunanusa Eramandiri Tbk PT
IDX:GUNA
|
ID |
|
E
|
Eurofins Scientific SE
DUS:ESF0
|
LU |
|
Agape ATP Corp
NASDAQ:ATPC
|
MY |
|
K
|
Kernel Holding SA
XMUN:0KE
|
UA |
|
T
|
Toronto-Dominion Bank
XMUN:TDB
|
CA |
|
V
|
Vectus Biosystems Ltd
ASX:VBS
|
AU |
|
Belite Bio Inc
NASDAQ:BLTE
|
US |
|
Anabatic Technologies Tbk PT
IDX:ATIC
|
ID |
|
J
|
Jabil Inc
SWB:JBL
|
US |
|
Y
|
Yulon Motor Co Ltd
TWSE:2201
|
TW |
|
Larsen and Toubro Ltd
F:LTO
|
IN |
|
Kering SA
XETRA:PPX
|
FR |
|
Macfarlane Group PLC
LSE:MACF
|
UK |
|
Iida Group Holdings Co Ltd
TSE:3291
|
JP |
|
T
|
Telstra Group Ltd
F:5KB
|
AU |
|
Wira Global Solusi Tbk PT
IDX:WGSH
|
ID |
|
V
|
Virgin Australia Holdings Ltd
ASX:VGN
|
AU |
|
G
|
Gaztransport et Technigaz SA
SWB:9TG
|
FR |
Akwel SA (0F8V)’s 12-month stock price forecast through October 2027 has a consensus target of €8.96, implying 34% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
0F8V is 8.96 EUR with a low forecast of 6.63 EUR and a high forecast of 11.55 EUR.
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is -2%.
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is -13%.
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is -2%.
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next -4 years is -21%.
Over the last 14 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 3 years is -5%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more